ClinicalTrials.Veeva

Menu
H

Hospital Tuanku Jaafar | Nephrology Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Guselkumab
Esketamine
Semaglutide
Icotrokinra
Zenagamtide
Sodium
Quetiapine XR
AK0529
Etelcalcetide
Serotonin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 26 total trials

A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity (AMBIENCE)

This clinical study is being conducted to evaluate the safety and effectiveness of zenagamtide in people with atherosclerotic cardiovascular disease...

Begins enrollment this month
Obesity
Cardiovascular Risk
Drug: Zenagamtide
Drug: Placebo

The purpose of this study is to compare the safety and efficacy of risankizumab versus placebo in participants with moderately to severely active pso...

Active, not recruiting
Psoriatic Arthritis
Biological: Placebo
Biological: Risankizumab

The purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) axial disease by...

Active, not recruiting
Arthritis, Psoriatic
Drug: Placebo
Drug: Guselkumab

The purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) by assessing the...

Active, not recruiting
Arthritis, Psoriatic
Drug: Placebo
Drug: Guselkumab

The purpose of this study is to evaluate the efficacy, including clinical remission of guselkumab subcutaneous (SC) induction compared to placebo in...

Active, not recruiting
Colitis, Ulcerative
Drug: Guselkumab Dose 2
Other: Placebo

The purpose of this study is to evaluate how-well icotrokinra works (clinical efficacy) and how safe it is (safety) in participants with moderately t...

Enrolling
Crohn Disease
Drug: Icotrokinra
Drug: Placebo

The purpose of this study is to evaluate the efficacy of icotrokinra (JNJ-77242113) compared to placebo in biologic-experienced and biologic-naive pa...

Enrolling
Arthritis, Psoriatic
Drug: Placebo
Drug: Icotrokinra

This is a phase 3 trial of etelcalcetide in pediatric participants with secondary hyperparathyroidism (SHPT) and chronic kidney disease (CKD) on hemo...

Enrolling
Chronic Kidney Disease
Secondary Hyperparathyroidism
Other: Standard of Care
Drug: Etelcalcetide

Trial sponsors

Janssen (J&J Innovative Medicine) logo
Novo Nordisk logo
H
AbbVie logo
Amgen logo
Janssen (J&J Innovative Medicine) logo
Janssen (J&J Innovative Medicine) logo
M
P
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems